Protocol for CRISPR-Cas12a genome editing of protein tyrosine phosphatases in human pluripotent stem cells and functional β-like cell generation
STAR Protocols · 2024
DOI: 10.1016/j.xpro.2024.103297 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift STAR Protocols, 2024. Verfasst von Javier Negueruela und 7 weiteren Autor:innen. Beteiligte Einrichtung: Signal Transduction and Metabolism Laboratory, Université libre de Bruxelles, Anderlecht, 1070 Brussels-Capital Region, Belgium. Electronic address: …. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems, Pluripotent Stem Cells, Insulin-Secreting Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Research Council, JDRF, Helsingin Yliopisto.
Abstract (Originalsprache)
Gene editing of human pluripotent stem cells is a promising approach for developing targeted gene therapies for metabolic diseases. Here, we present a protocol for generating a CRISPR-Cas12a gene knockout of protein tyrosine phosphatases in human embryonic stem cells. We describe steps for differentiating the edited clones into pancreatic islet-like spheroids rich in β-like cells. We then detail procedures for implanting these spheroids under the murine kidney capsule for in vivo maturation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Signal Transduction and Metabolism Laboratory, Université libre de Bruxelles, Anderlecht, 1070 Brussels-Capital Region, Belgium. Electronic address: javier.negueruela.escudero@ulb.be.
- Signal Transduction and Metabolism Laboratory, Université libre de Bruxelles, Anderlecht, 1070 Brussels-Capital Region, Belgium.
- Signal Transduction and Metabolism Laboratory, Université libre de Bruxelles, Anderlecht, 1070 Brussels-Capital Region, Belgium. Electronic address: mayank.bansal@ulb.be.
- Signal Transduction and Metabolism Laboratory, Université libre de Bruxelles, Anderlecht, 1070 Brussels-Capital Region, Belgium. Electronic address: esteban.gurzov@ulb.be.
Förderung
- European Research Council
- JDRF
- Helsingin Yliopisto
- Juvenile Diabetes Research Foundation United States of America
- FRS-FNRS
Zitieren
APA
Negueruela, J., Vandenbempt, V., Talamantes, S., Ribeiro-Costa, F., Nunes, M., Dias, A., Bansal, M., & Gurzov, E. N. (2024). Protocol for CRISPR-Cas12a genome editing of protein tyrosine phosphatases in human pluripotent stem cells and functional β-like cell generation. STAR Protocols. https://doi.org/10.1016/j.xpro.2024.103297
Vancouver
Negueruela J, Vandenbempt V, Talamantes S, Ribeiro-Costa F, Nunes M, Dias A, et al. Protocol for CRISPR-Cas12a genome editing of protein tyrosine phosphatases in human pluripotent stem cells and functional β-like cell generation. STAR Protocols. 2024. doi:10.1016/j.xpro.2024.103297
BibTeX
@article{Negueruela2024,
author = {Negueruela, Javier and Vandenbempt, Valerie and Talamantes, Stephanie and Ribeiro-Costa, Francisco and Nunes, Mariana and Dias, André and Bansal, Mayank and Gurzov, Esteban N},
title = {Protocol for CRISPR-Cas12a genome editing of protein tyrosine phosphatases in human pluripotent stem cells and functional β-like cell generation},
journal = {STAR Protocols},
year = {2024},
doi = {10.1016/j.xpro.2024.103297}
}
EUVIMED